EUVIMEDEUVIMED entdecken
EditorialKommentar

Is adamgammadex the brother of sugammadex or the next generation of reversal agent?

Jennifer M Hunter, J Robert Sneyd

British Journal of Anaesthesia · 2024

DOI: 10.1016/j.bja.2023.11.006 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Anaesthesia, 2024. Verfasst von Jennifer M Hunter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aging and Chronic Disease, University of Liverpool, Liverpool, UK. Electronic address: bja@liverpool.ac.uk. Hauptthemen laut MEDLINE: Neuromuscular Blockade, Neuromuscular Nondepolarizing Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sugammadex is now in widespread use to reverse the neuromuscular blocking effects of rocuronium. Adverse effects from sugammadex are rare, but anaphylactic and cardiovascular reactions to the drug have been reported. In an attempt to reduce such side-effects, a modified gamma-cyclodextrin, adamgammadex, has been developed. Phase 3 clinical trials suggest that it is slightly less potent than sugammadex and has a non-inferior speed of onset. In a multicentre trial of 310 patients, there was a suggestion of a lower incidence of allergic responses and recurarisation after adamgammadex compared with sugammadex. The clinical implications of this study are discussed in this editorial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromuscular BlockadeNeuromuscular Nondepolarizing AgentsHumansRocuroniumSugammadexMulticenter Studies as TopicClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

adamgammadexcomplicationsneuromuscular blocknon-inferiorityphase 3 trialreversalrocuroniumsugammadex

Substanzen

Neuromuscular Nondepolarizing AgentsRocuroniumSugammadex

Autor:innen und Institutionen

  • Department of Aging and Chronic Disease, University of Liverpool, Liverpool, UK. Electronic address: bja@liverpool.ac.uk.
  • Faculty of Health, University of Plymouth, John Bull Building, Plymouth Science Park, Plymouth, UK.

Zitieren

APA

Hunter, J. M., & Sneyd, J. R. (2024). Is adamgammadex the brother of sugammadex or the next generation of reversal agent?. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2023.11.006

Vancouver

Hunter JM, Sneyd JR. Is adamgammadex the brother of sugammadex or the next generation of reversal agent?. British Journal of Anaesthesia. 2024. doi:10.1016/j.bja.2023.11.006

BibTeX
@article{Hunter2024,
  author = {Hunter, Jennifer M and Sneyd, J Robert},
  title = {Is adamgammadex the brother of sugammadex or the next generation of reversal agent?},
  journal = {British Journal of Anaesthesia},
  year = {2024},
  doi = {10.1016/j.bja.2023.11.006}
}
Kostenlos starten →